Clinical Trial Update: Study On Liprimar (Atorvastatin) In Patients With Coronary Heart Disease (CHD) And High Risk Of Cardiovascular Complications

View source ↗

Summary

Clinical trial update for atorvastatin (Liprimar) in patients with coronary heart disease at high cardiovascular risk; study completed with results posted in 20…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Diseases
• Coronary Artery Disease

Drugs mentioned

• Liprimar (atorvastatin)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Cardiovascular Diseases, Coronary Artery Disease | Status: COMPLETED | Results posted: 2012-12-20